PECULIARITIES OF RADIATION DIAGNOSTIC OF LUNGS WITH CYSTIC FIBROSIS
Abstract
Our method was used to clarify the possibilities of diagnostic in case of cystic fibrosis and the installation of a computer tomography place in a diagnostic algorithm. Consequently we have analyzed the results of cases of 5 patients at the age from 19 to 25 years with the diagnosis of cystic fibrosis confirmed by sweat samples and genetic investigations. From September 2017 to 2018, the patients were placed in the infection epidemic department No. 2 of Oleksandrivskiy Clinical Hospital die to complications of the main disease. The patients were in the group of middle and high level of severity, respiratory failure II, III stages. These patients were dynamically examined by digital radiography of the chest cavity organs “Radrex” by Toshiba. All of the patients were united by an young age, asthenic and low nutrition body structure, short stature and prolonged anamnesis from early childhood, anamnesis of respiratory diseases, acute respiratory viral infections, bronchitis, sinusitis of the maxillary antrum. It was proved that the results obtained by radiography are typical for CF, but not specific, as well as they could be found in other diffuse lung diseases. After multispiral Computer tomography scan, we have found the main symptoms of cystic fibrosis, such as: total systemic damage of bronchopulmonary structures, two-sides character of pulmonary bronchiectasis . The presence of pronounced dilation of the bronchi of all orders, at least 200% of the original size, with a consolidation and thickening of their walls: a symptom of "ring" and the symptom of "paired strips" and filling of abruptly dilated bronchi of all calibers with a viscous secretion and as a result of this the mucous plugs are formed.
Conclusion. The results of the X-ray examination are typical for CF and not specific, as well as for other diffuse pulmonary diseases. Computer tomography can be used for diagnostics of thin structurally functional particles characteristic for cystic fibrosis. It has also been established that the expression of morphological changes of cystic fibrosis are increased with the age of the patients. CT scan is the most useful for the detection morphological and functional changes for cystic fibrosis. Moreover, the CT scan is able to improve the early diagnoses for lungs pathology among the adolescent and the adults, and decrease the period of expectation of the result of the treatment.
References
Bulgakova, T. V., Ses`, T. P., Surkova, E. A., Zheleny`na, L. A., & Gemby`czkaya, T. E. (2000).Osobennosty` vospaly`tel`nogo processa u bol`nыx mukovy`scy`dozom. Medy`cy`nskaya y`mmunology`ya, 2(4) [Features of the inflammatory process in patients with cystic fibrosis.][Medical Immunology, 2 (4)] [in Russian]
Burns, J. L., Emerson, J., Stapp, J. R., Yim, D. L., Krzewinski, J., Louden, L., ... & Clausen, C. R. (1998). Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clinical Infectious Diseases, 27(1), 158-163.
Cain, C. (2012). Cystic fibrosis two-step. SciBX: Science-Business eXchange, 5(8).
Cholon, D. M., Quinney, N. L., Fulcher, M. L., Esther, C. R., Das, J., Dokholyan, N. V., ... & Gentzsch, M. (2014). Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis. Science translational medicine, 6(246), 246ra96-246ra96
Cystic Fibrosis Foundation. (2013). Cystic Fibrosis Foundation Patient Registry 2012 Annual Data Report.
Doring G. (2002). Chronic lung infection in cystic fibrosis // International congress and symposium series. 254. 5–15.
Flume, P. A., Liou, T. G., Borowitz, D. S., Li, H., Yen, K., Ordoñez, C. L., ... & VX 08-770-104 Study Group. (2012). Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation. Chest, 142(3), 718-724.
Heeley M.E., Woolf D.A., Heeley A.F. Indirect measurements of sweat electrolyte concentration in the laboratory diagnosis of cystic fibrosis // Arch. Dis. Child. 2000. Vol.82. P.420–424.
Kapranov, N. Y`. (2006). Mukovy`scy`doz–sovremennoe sostoyany`e problemi. Pul`monology`ya, 3(npy`l.), 3. [Cystic fibrosis - the current state of the problem.] [Pulmonology, 3(examp.), 3.] [in Russian]
Karczeski, B. A., & Cutting, G. R. (2006). Diagnosis of cystic fibrosis, CFTR-related disease and screening. In Cystic Fibrosis in the 21st Century (Vol. 34, pp. 69-76). Karger Publishers.
Kerem, B. S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., ... & Tsui, L. C. (1989). Identification of the cystic fibrosis gene: genetic analysis. Science, 245(4922), 1073-1080.
Koch, C. (2002). Early infection and progression of cystic fibrosis lung disease. Pediatric pulmonology, 34(3), 232-236
Kuo, W., Kemner-van de Corput, M. P., Perez-Rovira, A., De Bruijne, M., Fajac, I., Tiddens, H. A., & Van Straten, M. (2016). Multicentre chest computed tomography standardisation in children and adolescents with cystic fibrosis: the way forward. European Respiratory Journal, 47(6), 1706-1717.
Lowe, C. U., May, C. D., & Reed, S. C. (1949). Fibrosis of the pancreas in infants and children: a statistical study of clinical and hereditary features. American journal of diseases of children, 78(3), 349-374.
Pasteur, M. C., Helliwell, S. M., Houghton, S. J., Webb, S. C., Foweraker, J. E., Coulden, R. A., ... & Keogan, M. T. (2000). An investigation into causative factors in patients with bronchiectasis. American journal of respiratory and critical care medicine, 162(4), 1277-1284.
Phuan, P. W., Veit, G., Tan, J. A., Finkbeiner, W. E., Lukacs, G. L., & Verkman, A. S. (2015). Potentiators of Defective ΔF508–CFTR Gating that Do Not Interfere with Corrector Action. Molecular pharmacology, 88(4), 791-799.
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., ... & Moss, R. (2011). A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. New England Journal of Medicine, 365(18), 1663-1672.
Riordan, J. R., Rommens, J. M., Kerem, B. S., Alon, N., Rozmahel, R., Grzelczak, Z., ... & Chou, J. L. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 245(4922), 1066-1073.
Rommens, J. M., Iannuzzi, M. C., Kerem, B. S., Drumm, M. L., Melmer, G., Dean, M., ... & Hidaka, N. (1989). Identification of the cystic fibrosis gene: chromosome walking and jumping. Science, 245(4922), 1059-1065.
Rybacka, A., & Karmelita-Katulska, K. (2016). The Role of Computed Tomography in Monitoring Patients with Cystic Fibrosis. Polish journal of radiology, 81, 141.
Tiddens, H. A., Stick, S. M., & Davis, S. (2014). Multi-modality monitoring of cystic fibrosis lung disease: the role of chest computed tomography. Paediatric respiratory reviews, 15(1), 92-97.
Welsh, M. J., & Liedtke, C. M. (1986). Chloride and potassium channels in cystic fibrosis airway epithelia.
Zheleny`na, L. A., Efy`mova, N. S., Orlov, A. V., Kuropatenko, M. V., Ses`, T. P., Bulgakova, T. V., & Surkova, E. A. (2006). Atopy`ya y` gy`perreakty`vnost` bronxov pry` bronxoobstrukty`vnom sy`ndrome u bol`nыx mukovy`scy`dozom. Allergology`ya, 1, 10-14.[Atopy and bronchial hyperreactivity at bronchial obstructive syndrome in patients with cystic fibrosis]. [Allergology, 1, 10-14.][in Russian]
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 
ISSN 
